Kurt Jarnagin, based in San Mateo, California, United States, is currently a President and CSO at Rev Therapeutics, Inc., bringing experience from previous roles at Synbal, Inc., BioPharm Tech Consulting, AntibioTx A/S and Pfizer. Kurt Jarnagin holds a 1984 - 1986 Post Doctoral @ University of California, San Francisco. With a robust skill set that includes Drug Discovery, Biotechnology, Clinical Development, Marketing, Drug Development and more, Kurt Jarnagin contributes valuable insights to the industry. Kurt Jarnagin has 1 email on RocketReach.